Bifogade filer
IRRAS Q4 - Continues to lay the building blocks
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Redeye via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
2023-02-20 08:35:00
Redeye has a relatively neutral stance on IRRAS’ Q4 report, with sales coming in under and costs above our forecasts. We highlight the commercial partnership with Medtronic and argue that it underpins the potential of IRRAflow. The biggest concern in the short term is the company’s cash position, and we expect an equity issue towards the end of H1 2023e.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/